Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
---|
04/01/2010 | WO2010036698A1 Substituted alpha-l-bicyclic nucleosides |
04/01/2010 | WO2010036696A1 Cyclohexenyl nucleic acid analogs |
04/01/2010 | WO2010036323A1 Method of identifing interactions between genomic loci |
04/01/2010 | WO2010034115A1 Thermostable alcohol dehydrogenase derived from thermococcus guaymasensis |
04/01/2010 | WO2009139804A3 Biologically active recombinant human saposin c and psap |
04/01/2010 | US20100083409 Expression vector comprising genetic insulator elements for enhancing transcription of insect resistance genes |
04/01/2010 | US20100083408 Gene Expression Modulating Element |
04/01/2010 | US20100083407 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics |
04/01/2010 | US20100083405 Method For Controlling Seed Germination In Non-Dormant Seeds And Use Thereof |
04/01/2010 | US20100083403 Production of peptides and proteins by accumulation in plant endoplasmic reticulum-derived protein bodies |
04/01/2010 | US20100083399 COMPOSITIONS AND METHODS FOR ASSAYING MARKERS TIGHTLY LINKED TO RESISTANCE LOCUS Bs2 OF PEPPER |
04/01/2010 | US20100083396 Soybean Gene for Resistance to Aphis glycines |
04/01/2010 | US20100083392 Hafnia phytase variants |
04/01/2010 | US20100081801 Method for determining an unknown PNA sequence and uses thereof |
04/01/2010 | US20100081793 Therapeutic uses of humanized antibodies against alpha-4 integrin |
04/01/2010 | US20100081789 Novel Vectors for Production of Interferon |
04/01/2010 | US20100081712 Recombinant human factor ix and use thereof |
04/01/2010 | US20100081711 Cytotoxic agents |
04/01/2010 | US20100081710 Modified L-Nucleic Acid |
04/01/2010 | US20100081709 Isolated snare ykt6 genomic polynucleotide fragments from chomosome 7 and their uses |
04/01/2010 | US20100081708 Anticoagulant compounds |
04/01/2010 | US20100081706 Immunomodulatory oliogonucleotides and methods of use therefor |
04/01/2010 | US20100081705 Methods for slowing familial als disease progression |
04/01/2010 | US20100081704 Modulator compounds of the drug resistance in epithelial tumour cells |
04/01/2010 | US20100081627 Polymeric nucleoside prodrugs |
04/01/2010 | US20100081612 Polypeptide derivatives of parathyroid hormone (pth) |
04/01/2010 | US20100081581 Probe, probe set, probe-immobilized carrier, and genetic testing method |
04/01/2010 | US20100081211 Luminescent lanthanide labelling reagents and their use |
04/01/2010 | US20100081204 Nucelic-acid-responsive gel, method for producing same, and use of same |
04/01/2010 | US20100081198 Method for the repair of mutated rna from genetically defective dna and for the specific destruction of tumor cells by rna trans-splicing, and a method for the detection of naturally trans-spliced cellular rna |
04/01/2010 | US20100081193 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
04/01/2010 | US20100081192 Early prostate cancer antigens (epca), polynucleotide sequences encoding them, and their use |
04/01/2010 | US20100081147 Human catechol-o-methyltransferase (comt) assay |
04/01/2010 | US20100081140 Chemically cleavable phosphoramidite linkers for sequencing by ligation |
04/01/2010 | US20100081138 Nucleotide sequences for the detection of enterohaemorrhagic Escherichia coli (EHEC) |
04/01/2010 | US20100081137 Click Chemistry for the Production of Reporter Molecules |
04/01/2010 | US20100081133 Methods of Detecting Root Knot Nematodes |
04/01/2010 | US20100081124 Primers and probes for detecting human papillomavirus and human beta globin sequences in test samples |
04/01/2010 | US20100080887 Soybean plant with altered oil content (more oleic, less saturated fat); cooking oil, salad oil, shortening, lecithin, nontoxic plastics, printing inks, lubricants, waxes, hydraulic fluids, electric transformer fluids, solvents, cosmetics, hair care products and biodiesel |
04/01/2010 | US20100080850 Polypeptide ligands for targeting cartilage and methods of use thereof |
04/01/2010 | US20100080828 Immunogenic sequences |
04/01/2010 | US20100080817 HUMAN PAPILLOMAVIRUS / Ii-KEY HYBRIDS AND METHODS OF USE |
04/01/2010 | US20100080815 MN Gene and Protein |
04/01/2010 | US20100080813 Neutralizing anti-influenza a virus antibodies and uses thereof |
04/01/2010 | US20100080812 Antibodies against human IL17 and uses thereof |
04/01/2010 | US20100080809 Gitr ligand and gitr ligand-related molecules and antibodies and uses thereof |
04/01/2010 | US20100080801 Comprises nucleotide sequences coding antibody receptor for treating autoimmune and immunological diseases |
04/01/2010 | US20100080800 Humanized antibody |
04/01/2010 | US20100080799 Wstf regulates the dna damage response of h2a.x via novel tyrosine kinase activity |
04/01/2010 | US20100080794 Mutant polypeptide having effector function |
04/01/2010 | US20100080774 Lactococcus promoters and uses thereof |
04/01/2010 | CA2776044A1 Screening methods for identifying specific staphylococcus aureus inhibitors |
04/01/2010 | CA2738574A1 Thermostable alcohol dehydrogenase derived from thermococcus guaymasensis |
04/01/2010 | CA2738474A1 Soybean transgenic event mon87705 and methods for detection thereof |
03/31/2010 | EP2169076A2 Enzymes having alpha amylase activity and methods of use thereof |
03/31/2010 | EP2168973A1 Nucleic acid ligand complexes |
03/31/2010 | EP2167662A2 Pharmaceutical compounds comprising abasic oligonucleotides |
03/31/2010 | EP2167524A1 Methods of directly amplifying nucleic acids from crude samples |
03/31/2010 | CN101688327A Serpine1 polymorphisms are predictive of response to activated protein c administration and risk of death |
03/31/2010 | CN101688239A Early detection and prognosis of colon cancers |
03/31/2010 | CN101687901A corn polymorphisms and methods of genotyping |
03/31/2010 | CN101687900A Double-stranded locked nucleic acid compositions |
03/31/2010 | CN101687050A Methods and materials for identifying the origin of a carcinoma of unknown primary origin |
03/31/2010 | CN101687005A Methods for treating cancer using agents that inhibit wnt16 signaling |
03/31/2010 | CN101684147A moraxella catarrhalis proteins |
03/31/2010 | CN101684138A Kit using nanometer magnetic beads for purifying nucleic acid |
03/31/2010 | CN101684137A Method for extracting total DNA of microorganism in liquor Daqu |
03/30/2010 | US7687618 Method of manufacturing labelled oligonucleotide conjugates |
03/30/2010 | US7687617 Oligonucleotides with alternating segments of locked and non-locked nucleotides |
03/30/2010 | US7687616 for therapy that allows inter alia up-regulation of a disease-related target gene of novel GAM oligonucleotides of the present invention, by countering the activity of a GAM oligonucleotides which naturally inhibits expression of that target gene |
03/30/2010 | US7687615 PAV regions for encapsidation and E1 transcriptional control |
03/30/2010 | US7687614 Monomeric and dimeric fluorescent protein variants and methods for making same |
03/30/2010 | US7687610 having an increased activity over the wild-type human glycoprotein; reproduction disorders; cancer such as thyroid carcinoma |
03/30/2010 | US7687475 RNA interference in respiratory epithelial cells |
03/30/2010 | US7687256 bioanalytical microarray comprising surface with microlocations in discrete regions and forms pattern; each microlocation has dose density of implanted ions and functions as potential energy location; exhibits affinity for compound different from surface; plurality of macromolecules in microlocations |
03/30/2010 | US7687254 homogenizing biological material with homogenization buffer to form homogenate; proteins and non-DNA organic molecules are extracted from homogenate by mixing first extraction buffer and second extraction buffer with the homogenate; DNA is precipitated from mixture, recovered by sedimentation |
03/30/2010 | US7687253 Escherichia coli strains which over-produce L-threonine and processes for the production of L-threonine by fermentation |
03/30/2010 | US7687247 Process for controlling contamination of nucleic acid amplification reactions |
03/30/2010 | US7687236 Fluorescent nucleobase conjugates having anionic linkers |
03/30/2010 | US7687233 Methods and compositions for the correlation of single nucleotide polymorphisms in the vitamin K epoxide reductase gene and warfarin dosage |
03/30/2010 | US7687058 Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases |
03/30/2010 | CA2491887C Modified inosine monophosphate dehydrogenases |
03/30/2010 | CA2409347C Enhanced protein thermostability and temperature resistance |
03/30/2010 | CA2403326C Methods of protein detection utilizing cleavable identifying tags |
03/30/2010 | CA2170523C Cloned glutamic acid decarboxylase |
03/30/2010 | CA2162150C Germline mutations in the mts gene and method for detecting predisposition to cancer at the mts gene |
03/30/2010 | CA2155004C Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
03/30/2010 | CA2144223C Effector proteins of rapamycin |
03/30/2010 | CA2139070C Method for enhancing detection ability of nucleic acid assays employing polymerase chain reaction |
03/25/2010 | WO2010034024A2 Protected monomers and methods of deprotection for rna synthesis |
03/25/2010 | WO2010033753A2 Mutant delta5 desaturases and their use in making polyunsaturated fatty acids |
03/25/2010 | WO2010033688A2 Nucleic acids encoding spider glue proteins and methods of use thereof |
03/25/2010 | WO2010033667A2 Wstf regulates the dna damage response of h2a.x via novel tyrosine kinase activity |
03/25/2010 | WO2010033652A1 Method for small rna isolation |
03/25/2010 | WO2010033619A2 Systems, methods, and compositions for detection of human papilloma virus in biological samples |
03/25/2010 | WO2010033225A2 Compositions and methods for the specific inhibition of gene expression by dsrna possessing modifications |
03/25/2010 | WO2010014572A3 Modulation of toll-like receptor 9 expression by antisense oligonucleotides |
03/25/2010 | WO2009149253A3 Mrna cap analogs |
03/25/2010 | WO2009131919A8 Polymerases for incorporating modified nucleotides |
03/25/2010 | WO2009099580A3 Transgenic soy plants with enhanced agronomic traits |